"...this time though I feel they want this out of their hair."
Why? What has been released that makes you feel this way? I saw nothing to make this statement WRT the FDA's sentiments toward DefenCath.
In fact, all this re-file or not discussion is probably better answered by a call to CRMD's Investor relations...assuming you can call it that. Or a direct email to Todisco himself.
Maybe, altho somewhat doubtful based on past attempts to clarify other things, but maybe they'll actually give a straight answer under our new CEO. That is, IF they respond at all.